Maruo Calcium Co., Ltd.
Maruo Calcium Co., Ltd. Second Quarter (Interim) Financial Summary [Japanese GAAP] (Consolidated)
For the interim period of the fiscal year ending March 2027, consolidated results recorded net sales of 6,857 million yen, up 13.7% year-over-year; operating income of 56 million yen; ordinary income of 159 million yen; and net income attributable to owners of parent of 154 million yen, returning to profitability. The full-year forecast remains unchanged from the previous announcement. Financial position: total assets of 18,355 million yen, equity ratio of 58.5%, and shareholders' equity of 1,074.5 million yen.
Key Figures
- Net Sales: 6,857 million yen (Up 13.7% year-over-year)
- Operating Income: 56 million yen (Previous interim period recorded a loss of -21 million yen)
- Net Income Attributable to Owners of Parent: 154 million yen (Up 78.4% year-over-year)
AI要約
Key Points of Performance
Maruo Calcium achieved increased revenue in 2Q of fiscal 2027 with net sales of 6,857 million yen (up 13.7% year-over-year). Operating income turned positive to 56 million yen, ordinary income was 159 million yen, and net income attributable to owners of parent was 154 million yen, significantly exceeding the prior year. Total assets stood at 18,355 million yen and the equity ratio was 58.5%. Improvements in liquidity, centered on cash and deposits, were also observed. The financial summary explicitly states there are no revisions to the initial full-year forecasts, indicating no changes to forward-looking projections at this time.
Outlook and Points to Note
The solid interim performance reflects the effects of cost reductions and revised selling prices. The full-year forecasts remain as previously announced with no revisions, but continued attention is required regarding the trends in sales and profits. The financial position is sound with a high equity ratio. Whether the positive factors in cash management will continue is a key focus going forward.
Maruo Calcium Co., Ltd.
Company overview · Stock price · Financial data · All IR
